Slovenija - slovenščina - Ecolab

ecolab deutschland gmbh -

Evropska unija - slovenščina - EMA (European Medicines Agency)

bayer ag - riociguat - hipertenzija, pljučnica - antihipertenzivi za pljučno arterijsko hipertenzijo - chronic thromboembolic pulmonary hypertension (cteph)adempas is indicated for the treatment of adult patients with who functional class (fc) ii to iii withinoperable cteph,persistent or recurrent cteph after surgical treatment,to improve exercise capacity. pulmonary arterial hypertension (pah)adultsadempas, as monotherapy or in combination with endothelin receptor antagonists, is indicated for the treatment of adult patients with pulmonary arterial hypertension (pah) with who functional class (fc) ii to iii to improve exercise capacity. učinkovitosti je bil prikazan v pah prebivalstva, vključno z aetiologies z idiopatsko ali dedne pah ali pah, povezanih z vezivnega tkiva bolezni. paediatricsadempas is indicated for the treatment of pah in paediatric patients aged less than 18 years of age and body weight ≥ 50 kg with who functional class (fc) ii to iii in combination with endothelin receptor antagonists.

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

iris d.o.o. - raztopina za kožni vbodni test - alergenski ekstrakti

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

medias international d.o.o. - bakrov(ii) klorid dihidrat; cinkov klorid; kalijev jodid; kromov(iii) klorid heksahidrat; manganov(ii) klorid tetrahidrat; natrijev fluorid; natrijev molibdat dihidrat; natrijev selenit, brezvodni; železov(iii) klorid heksahidrat - koncentrat za raztopino za infundiranje - bakrov(ii) klorid dihidrat 340 µg / 1 ml  cinkov klorid1360 µg / 1 ml  kalijev jodid16,6 µg / 1 ml  kromov(iii) klorid heksahidrat5,33 µg / 1 ml  manganov(ii) klorid tetrahidrat99 µg / 1 ml  natrijev fluorid210 µg / 1 ml  natrijev molibdat dihidrat4,85 µg / 1 ml  natrijev selenit, brezvodni6,9 µg / 1 ml  železov(iii) klorid heksahidrat540 µg / 1 ml; cinkov klorid 1360 µg / 1 ml  kalijev jodid16,6 µg / 1 ml  kromov(iii) klorid heksahidrat5,33 µg / 1 ml  manganov(ii) klorid tetrahidrat99 µg / 1 ml  natrijev fluorid210 µg / 1 ml  natrijev molibdat dihidrat4,85 µg / 1 ml  natrijev selenit, brezvodni6,9 µg / 1 ml  železov(iii) klorid heksahidrat540 µg / 1 ml; kalijev jodid 16,6 µg / 1 ml  kromov(iii) klorid heksahidrat5,33 µg / 1 ml  manganov(ii) klorid tetrahidrat99 µg / 1 ml  natrijev fluorid210 µg / 1 ml  natrijev molibdat dihidrat4,85 µg / 1 ml  natrijev selenit, brezvodni6,9 µg / 1 ml  železov(iii) klorid heksahidrat540 µg / 1 ml; kromov(iii) klorid heksahidrat 5,33 µg / 1 ml  manganov(ii) klorid tetrahidrat99 µg / 1 ml  natrijev fluorid210 µg / 1 ml  natrijev molibdat dihidrat4,85 µg / 1 ml  natrijev selenit, brezvodni6,9 µg / 1 ml  železov(iii) klorid heksahidrat540 µg / 1 ml; manganov(ii) klorid tetrahidrat 99 µg / 1 ml  natrijev fluorid210 µg / 1 ml  natrijev molibdat dihidrat4,85 µg / 1 ml  natrijev selenit, brezvodni6,9 µg / 1 ml  železov(iii) klorid heksahidrat540 µg / 1 ml; natrijev fluorid 210 µg / 1 ml  natrijev molibdat dihidrat4,85 µg / 1 ml  natrijev selenit, brezvodni6,9 µg / 1 ml  železov(iii) klorid heksahidrat540 µg / 1 ml; natrijev molibdat dihidrat 4,85 µg / 1 ml  natrijev selenit, brezvodni6,9 µg / 1 ml  železov(iii) klorid heksahidrat540 µg / 1 ml; natrijev selenit, brezvodni; železov(iii) klorid heksahidrat 540 µg / 1 ml - kombinacije elektrolitov z drugimi učinkovinami

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

medias international d.o.o. - bakrov(ii) klorid dihidrat; cinkov klorid; kalijev jodid; manganov(ii) klorid tetrahidrat; natrijev fluorid; natrijev selenit, brezvodni - koncentrat za raztopino za infundiranje - bakrov(ii) klorid dihidrat 53,7 µg / 1 ml  cinkov klorid521 µg / 1 ml  kalijev jodid1,31 µg / 1 ml  manganov(ii) klorid tetrahidrat3,6 µg / 1 ml  natrijev fluorid126 µg / 1 ml  natrijev selenit, brezvodni4,38 µg / 1 ml; cinkov klorid 521 µg / 1 ml  kalijev jodid1,31 µg / 1 ml  manganov(ii) klorid tetrahidrat3,6 µg / 1 ml  natrijev fluorid126 µg / 1 ml  natrijev selenit, brezvodni4,38 µg / 1 ml; kalijev jodid 1,31 µg / 1 ml  manganov(ii) klorid tetrahidrat3,6 µg / 1 ml  natrijev fluorid126 µg / 1 ml  natrijev selenit, brezvodni4,38 µg / 1 ml; manganov(ii) klorid tetrahidrat 3,6 µg / 1 ml  natrijev fluorid126 µg / 1 ml  natrijev selenit, brezvodni4,38 µg / 1 ml; natrijev fluorid 126 µg / 1 ml  natrijev selenit, brezvodni4,38 µg / 1 ml; natrijev selenit, brezvodni 4,38 µg / 1 ml - kombinacije elektrolitov z drugimi učinkovinami

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

medias international d.o.o. - bakrov(ii) klorid dihidrat; cinkov klorid; kalijev jodid; kromov(iii) klorid heksahidrat; manganov(ii) klorid tetrahidrat; natrijev fluorid; natrijev molibdat dihidrat; natrijev selenit, brezvodni; železov(iii) klorid heksahidrat - koncentrat za raztopino za infundiranje - bakrov(ii) klorid dihidrat 102,3 µg / 1 ml  cinkov klorid1050 µg / 1 ml  kalijev jodid16,6 µg / 1 ml  kromov(iii) klorid heksahidrat5,33 µg / 1 ml  manganov(ii) klorid tetrahidrat19,8 µg / 1 ml  natrijev fluorid210 µg / 1 ml  natrijev molibdat dihidrat4,85 µg / 1 ml  natrijev selenit, brezvodni17,3 µg / 1 ml  železov(iii) klorid heksahidrat540 µg / 1 ml; cinkov klorid 1050 µg / 1 ml  kalijev jodid16,6 µg / 1 ml  kromov(iii) klorid heksahidrat5,33 µg / 1 ml  manganov(ii) klorid tetrahidrat19,8 µg / 1 ml  natrijev fluorid210 µg / 1 ml  natrijev molibdat dihidrat4,85 µg / 1 ml  natrijev selenit, brezvodni17,3 µg / 1 ml  železov(iii) klorid heksahidrat540 µg / 1 ml; kalijev jodid 16,6 µg / 1 ml  kromov(iii) klorid heksahidrat5,33 µg / 1 ml  manganov(ii) klorid tetrahidrat19,8 µg / 1 ml  natrijev fluorid210 µg / 1 ml  natrijev molibdat dihidrat4,85 µg / 1 ml  natrijev selenit, brezvodni17,3 µg / 1 ml  železov(iii) klorid heksahidrat540 µg / 1 ml; kromov(iii) klorid heksahidrat 5,33 µg / 1 ml  manganov(ii) klorid tetrahidrat19,8 µg / 1 ml  natrijev fluorid210 µg / 1 ml  natrijev molibdat dihidrat4,85 µg / 1 ml  natrijev selenit, brezvodni17,3 µg / 1 ml  železov(iii) klorid heksahidrat540 µg / 1 ml; manganov(ii) klorid tetrahidrat 19,8 µg / 1 ml  natrijev fluorid210 µg / 1 ml  natrijev molibdat dihidrat4,85 µg / 1 ml  natrijev selenit, brezvodni17,3 µg / 1 ml  železov(iii) klorid heksahidrat540 µg / 1 ml; natrijev fluorid 210 µg / 1 ml  natrijev molibdat dihidrat4,85 µg / 1 ml  natrijev selenit, brezvodni17,3 µg / 1 ml  železov(iii) klorid heksahidrat540 µg / 1 ml; natrijev molibdat dihidrat 4,85 µg / 1 ml  natrijev selenit, brezvodni17,3 µg / 1 ml  železov(iii) klorid heksahidrat540 µg / 1 ml; natrijev selenit, brezvodni; železov(iii) klorid heksahidrat 540 µg / 1 ml - kombinacije elektrolitov z drugimi učinkovinami

Evropska unija - slovenščina - EMA (European Medicines Agency)

a.c.o.m. - advanced center oncology - baker (64cu) klorid - radionuklidno slikanje - various diagnostic radiopharmaceuticals - cuprymina je predhodnik radiofarmaka. niso namenjeni za neposredno uporabo pri bolnikih. to zdravilo je uporabiti le za radioaktivno označevanje prevoznika molekul, ki so bili posebej razviti in dovoljenje za radioaktivno označevanje s tem radionuklida.

Evropska unija - slovenščina - EMA (European Medicines Agency)

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - cepiva - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. uporaba tega cepiva mora biti v skladu z uradnimi priporočili.

Evropska unija - slovenščina - EMA (European Medicines Agency)

dynavax gmbh - površinski antigen hepatitisa b - hepatitis b - cepiva - heplisav b is indicated for the active immunisation against hepatitis b virus infection (hbv) caused by all known subtypes of hepatitis b virus in adults 18 years of age and older. the use of heplisav b should be in accordance with official recommendations. it can be expected that hepatitis d will also be prevented by immunisation with heplisav b as hepatitis d (caused by the delta agent) does not occur in the absence of hepatitis b infection.

Slovenija - slovenščina - Ecolab

ecolab deutschland gmbh -